Ding, C., Cao, Z., Li, J., Wei, W., Zhang, Q., Han, Z., Wang, J., Zhang, Y., Zhang, Y., Zhu, X., Li, H., Wu, S., He, Y., Wei, L. (2026). Perioperative therapy with tifcemailmab plus toripalimab and chemotherapy for resectable thoracic esophageal squamous cell carcinoma (BT-NICE trial): A prospective phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4087